Side Effects and Adverse Events of Vaccines against COVID-19
DOI:
https://doi.org/10.58987/3v7y0r23Keywords:
Vaccinations, COVID-19, Side Effects, Adverse Events, Old IndividualsAbstract
This study is to identify the side effects of vaccinations for Libyan individuals to protect from the Covid-19 virus, and it is to determine the actual COVID-19 vaccine with less adverse events or complications. The present work was conducted on different medical centers in the east, west, south and central regions of Libya in the period from1/9/2020 to 1/9/2021. About 989 vaccinated individuals (537 males and 452 females) aged (20-70) years were selected according to their symptoms after taking the vaccine. A several doctors and nurses from the east, west and south and central regions of Libya were subjected to provide details about the vaccinated individuals. The questionnaire form includes questions about effectiveness and types of vaccine, vaccine’s symptoms; the most resistant age group, the most age group had a high death rate, and the safest vaccines. The largest number of reported vaccinated cases was from western region (n =652), especially Tripoli (n= 466). Old individuals had more side effects than young people. Old men had more side effects than old women. No cases reported from Ghat city in southern Libya because of long distance or poor communication affected on and data transmission. The main side effects from vaccination included headache, pain, bleeding, fatigue, muscle pain, cough, and swelling. The descending order of vaccination according to side effects includes AstraZeneca (58%), Sputnik V (30%), Sinopharm (9%) and Pfizer (2%). This indicates that Pfizer vaccine is the safest vaccine than other vaccination. 574 (58%) cases were fully recovered from side effects, 33 (3 %) were died after taking the vaccination, while 9 (0.9%) cases are still under treatment.
References
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Retention of Rights: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
2. User Rights: This license allows others to remix, tweak, and build upon the work non-commercially, and although their new works must also acknowledge the original author and be non-commercial, they do not have to license their derivative works on the same terms.
3. Restrictions: The material cannot be used for commercial purposes without prior written permission from the author or the journal.
4. Additional Agreements: Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository), with an acknowledgement of its initial publication in this journal.